Close Access Denial: Cyberphysical Protection for High Value Assets with Lennart Koopmann LimaCharlie Jul 18, 2025 LimaCharlie Share: Share on Facebook Share on Bluesky Share on LinkedIn Share through email Lennart Koopmann, founder of Nzyme, joined Defender Fridays to discuss close access denial strategies. Register for the series: https://limacharlie.io/defender-fridays
